Strategies for targeting tumors and tumor vasculature for cancer therapy (Q37784291)

23 August 2017

Strategies for targeting tumors and tumor vasculature for cancer therapy (English)

1 reference

23 August 2017

Prashanth Sreeramoju

1

1 reference

PubMed ID

20807606

23 August 2017

Steven K Libutti

series ordinal

2

1 reference

23 August 2017

1 January 2010

1 reference

23 August 2017

1 reference

23 August 2017

69

1 reference

23 August 2017

135-152

1 reference

Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Vectors derived from the human immunodeficiency virus HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

VEGF-targeted therapy: mechanisms of anti-tumour activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

The Bakerian Lecture: Experimental Relations of Gold (and Other Metals) to Light

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Phase I clinical trial of recombinant human tumor necrosis factor in children with refractory solid tumors: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Isolated limb perfusion with tumor necrosis factor and melphalan prevents amputation in patients with multiple sarcomas in arm or leg.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Solid tumor therapy: manipulation of the vasculature with TNF.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Design and construction of targeted AAVP vectors for mammalian cell transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Low-dose tumour necrosis factor alpha and melphalan in hyperthermic isolated limb perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Fibroblast growth factor receptor is a portal of cellular entry for herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Murine leukemia induced by retroviral gene marking

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Incorporation of tumor vasculature targeting motifs into moloney murine leukemia virus env escort proteins enhances retrovirus binding and transduction of human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

In vivo efficacy of HSV-TK transcriptionally targeted to the tumour vasculature is augmented by combination with cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Percutaneous hepatic perfusion in patients with metastatic liver cancer: anesthetic, hemodynamic, and metabolic considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

A DNA-based method for rationally assembling nanoparticles into macroscopic materials

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Selective and persistent deposition and gradual drainage of iodized oil, Lipiodol in the hepatocellular carcinoma after injection into the feeding hepatic artery

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Colloidal gold: a novel nanoparticle for targeted cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

The distribution and radiation effects of intravenously administered colloidal Au198 in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Human gene marker/therapy clinical protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Vector-mediated cancer gene therapy: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Development of lentiviral vectors for antiangiogenic gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Antiangiogenic gene therapy: disruption of neovascular networks mediated by inducible caspase-9 delivered with a transcriptionally targeted adenoviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Antiangiogenic gene therapy of cancer: recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Tumor vasculature-targeted delivery of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Tissue-specific gene therapy directed to tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Postchemoembolisation syndrome – tumour necrosis or hepatocyte injury?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

Interstitial hydraulic conductivity in a fibrosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2810%2969015-3

7 January 2021

10.1016/S0065-2660(10)69015-3

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20807606